Destroying viruses at their shell's resonant frequencies

Applying energy at the virus' shell (capsid) resonant frequencies can offer highly-responsive alternative to treat infected people and surfaces.

Laziz Turakulov, who has more than 20 years of IT experience in the Operations, Marketing, Finance and R&D areas, and holds various Microsoft, Google, Amazon and SAP certifications.

Response time to the virus mutations in the pharmaceutical industry is quite slow: you need at least several months to adjust the vaccine, conduct the tests, secure approvals from the authorities and, finally, release your new formula to the production line. By that time, there are potentially more newer variants / strains of the virus already spreading.

On the example of Covid, we could see the race between leading pharma companies to develop a vaccine (with efficiency of 76% and above), and then reports published by the same vendors and local health authorities that their vaccines are less effective against the new Kent, South Africa and Brazil variants of coronavirus.

Our solution focuses on the protective shell of the Covid virus to destroy it. High-tech generators may allow adjustments to the new constraints programmatically, by generating the signal at the required frequencies, reducing response time from months to, possibly, days or even hours.

Equipped with semiconductor generators (which may be powered by our smartphones), we can provide people around the world with the cheap and effective disinfectors to destroy covid viruses: e.g., to clean spaces on the public transport or in the offices.

Once the clinical studies are conducted with the biomaterials, such generators can be potentially used to destroy the colony of viruses inside the human body: in their lungs and kidneys. Signal range should be sufficient enough to penetrate the tissue, but without harmful ionisation that we get, say, with X-ray exposure.

With the vaccine deployment, we can see that disproportionally the biggest volumes of vaccines are bought by the developed countries, which have financial capabilities to fund the purchase and distribution of the vaccine to their population.

Poor / developing countries are in less beneficial position, as they already struggle with the impact of Covid on their economics and cannot afford mass-vaccination.

We want our solution to become open-sourced, so that the tech can be built on-sites using recommendations / design files. And central database of the frequencies to become available globally and for free, so that the tested resonant frequencies immediately become available for the use by the local population / health authorities.

This publication in The Lancet, a very respected medical journal highlights scarcity in the Covid vaccine supply and disproportional buy-out of it by the handful number of developed countries: https://www.thelancet.com/jour...

Making an open-source solution that describes the design and supported by the global scientific and biomedical communities can enable free and global availability of this technology to respond to and treat the effects of the viruses like Covid, and enable fast-response for the potential future pandemics.

So, it may help to enable access to the alternative technologies to fight coronavirus and other bio-threats in the future in any part of the world. and through that generate a very tangible impact on delivering the latest health-support high-tech solutions to the hands of whose who are in the biggest need, irrespective of their country's financial, political and economical status.

If successful, in one year we should be able to enable free and direct access to the generator design and resonant frequency database to any health organisation and technology enthusiasts around the world.

In 3 years time, this may become a standard platform to exchange biomedical data on the potential biohazards / pandemics, and enable faster response in our inter-connected world. Something that we could greatly benefit in 2020 after the first reports from Wuhan, and thus could save millions of lives globally.

Getting first working prototype working will be the biggest and main milestone. The rest should be then become a history - as the global community can pick-up, develop and re-distribute such open source technology to support healthcare, transportation, hospitality and other industries.

There are 2 main barriers at the moment: technical and financial.

We hope that the quality of PoC research will enable us to work with the Trinity Challenge Member organisations to get advantage of their clinical studies / R&D capabilities and prove that this tech can be moved from PoC into prototype development phase.

And financial barrier then will become less relevant, as publishing the design and data as an open source can help to build a global community, to use the power of the human society (microbiologists, data scientists, medical researchers, technology enthusiasts) to fine-tune and practically enable access to the solution around the world.

None

We strongly believe that this idea can change the way we respond to and fight with pandemics like Covid. It's a deviation from the traditional way of relying on Big Pharma to develop vaccines (which still have its value and purpose), and provide alternative solutions on how we can disinfect our environment with the highly-adjustable semiconductor generators to destroy viruses at their resonant frequencies. Plus, enable new ways to treat affected people in the hospitals to destroy viruses inside their bodies with the minimal health on their health, but with the target on specific strains / variants of viruses.

Ideally, we would like to partner with the Trinity Challenge Member organisations who have their own biomedical research capabilities and ML expertise (e.g., Microsoft R&D or Google X, aka "Moonshot Factory"), or who can introduce to their own partners / networks with such capabilities.

This can help us to conduct more through research, practically prove the solution and then release the data / design to the rest of the world for their re-use as an open source innovation.